Quest Diagnostics
$231.09Change from previous close: −0.85%Absolute change: −$1.98
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $25.51B
- Enterprise value
- $31.67B
- P/E (trailing 12 months)
- 24.7
- Forward P/E
- 19.2
- PEG
- 1.52
- Price/book
- 3.38
- Price/sales
- 2.21
- EV/EBITDA
- 14.0
- EV/revenue
- 2.74
Profitability and growth
- Gross margin
- 33.2%
- Operating margin
- 15.2%
- Net margin
- 9.2%
- ROE
- 14.6%
- ROA
- 6.4%
- Revenue growth (year over year)
- 10.2%
- Earnings growth (year over year)
- 15.0%
Financial health
- Total cash
- $626M
- Total debt
- $6.4B
- Debt/equity
- 0.81
- Current ratio
- 1.59
- Quick ratio
- 1.28
Dividends
- Annual dividend per share
- $3.44
- Dividend yield
- 1.5%
- Payout ratio
- 26.1%
- Ex-dividend date
- October 6, 2026
Analysts and estimates
- Average price target
- $247.73
- Median price target
- $250.00
- High price target
- $265.00
- Low price target
- $204.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- $12.06
- EPS estimate, current year
- $11.19
Shares and trading
- Beta
- 0.55
- Average volume
- 1.02M
- Shares outstanding
- 110.37M
- Float
- 109.81M
- Institutional ownership
- 98.9%
- Insider ownership
- 0.4%
- Short interest (% of float)
- 3.3%
- Short ratio (days)
- 3.86